Back

Multimodal autonomic arousal tracks dose-dependent affective dynamics during the acute effects of DMT

D'Amelio, T. A.; Gil Garbagnoli, T.; Rodriguez Cuello, J.; Lewis-Healey, E.; Pallavicini, C.; Cavanna, F.; Bruno, N.; de la Fuente, L. A.; Muller, S. A.; Copa, D.; Bekinschtein, T.; Vidaurre Henche, D.; Tagliazucchi, E.

2026-05-04 neuroscience
10.64898/2026.04.30.721872 bioRxiv
Show abstract

Serotonergic psychedelics induce altered states of consciousness characterised by profound changes in emotional experience. Although psychedelics modulate autonomic arousal, sympathetic engagement during their affective effects remains poorly characterised. We recorded cardiac, electrodermal, and respiratory activity in 19 participants following inhalation of 20 or 40 mg of freebase N,N-dimethyltryptamine (DMT) under a semi-naturalistic blinded design, alongside time-resolved retrospective phenomenological reports. DMT induced robust increases across all autonomic markers, integrated into a multimodal index that selectively tracked subjective emotional intensity. Dose-dependent divergence followed modality-specific profiles: heart rate and respiratory differences emerged within the first 2 min post-inhalation, whereas electrodermal activity diverged only during the later phase, with higher doses showing prolonged autonomic engagement. DMT thus produces a transient sympathetic activation co-varying with emotional arousal, followed by gradual disengagement accompanied by pleasantness and bliss. By combining time- and cost-effective peripheral physiological measures with time-resolved phenomenological reports, this work contributes to the objective characterisation of psychedelic-induced affective states and provides a methodological basis for future biomarker research in clinical applications.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Scientific Reports
3102 papers in training set
Top 3%
12.6%
2
Neuropsychopharmacology
134 papers in training set
Top 0.3%
8.6%
3
Translational Psychiatry
219 papers in training set
Top 0.8%
7.0%
4
eBioMedicine
130 papers in training set
Top 0.1%
6.5%
5
Nature Communications
4913 papers in training set
Top 32%
5.0%
6
Journal of Psychopharmacology
14 papers in training set
Top 0.1%
3.3%
7
eLife
5422 papers in training set
Top 31%
2.8%
8
European Neuropsychopharmacology
15 papers in training set
Top 0.1%
2.7%
9
NeuroImage
813 papers in training set
Top 3%
2.5%
50% of probability mass above
10
Advanced Science
249 papers in training set
Top 8%
2.1%
11
Brain
154 papers in training set
Top 2%
2.1%
12
Molecular Psychiatry
242 papers in training set
Top 2%
1.9%
13
Psychopharmacology
59 papers in training set
Top 0.3%
1.9%
14
Brain, Behavior, and Immunity
105 papers in training set
Top 1%
1.8%
15
Pain
70 papers in training set
Top 0.5%
1.7%
16
Communications Biology
886 papers in training set
Top 8%
1.7%
17
PLOS ONE
4510 papers in training set
Top 57%
1.4%
18
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.5%
1.4%
19
Clinical and Translational Science
21 papers in training set
Top 0.6%
1.3%
20
iScience
1063 papers in training set
Top 21%
1.3%
21
ACS Chemical Neuroscience
60 papers in training set
Top 2%
1.3%
22
International Journal of Molecular Sciences
453 papers in training set
Top 11%
1.0%
23
Journal of Translational Medicine
46 papers in training set
Top 2%
0.9%
24
British Journal of Pharmacology
34 papers in training set
Top 0.4%
0.9%
25
Biomedicine & Pharmacotherapy
43 papers in training set
Top 0.8%
0.9%
26
Imaging Neuroscience
242 papers in training set
Top 3%
0.9%
27
npj Digital Medicine
97 papers in training set
Top 3%
0.9%
28
Neurobiology of Disease
134 papers in training set
Top 4%
0.8%
29
Neuropharmacology
60 papers in training set
Top 0.6%
0.8%
30
PLOS Biology
408 papers in training set
Top 19%
0.8%